Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.01.16.699838

Reliability and validity of multi-band multi-echo fMRI

Abstract

Precision mapping of individual differences in human brain spontaneous activity is critical for characterizing brain function and guiding clinical translation. Multi-echo resting-state functional MRI (ME-rfMRI) has the potential to provide more reliable mapping of inter-individual differences in intrinsic brain function than conventional single-echo rfMRI (SE-rfMRI). However, the psychometric benefits of ME-rfMRI for mapping individual differences in spontaneous brain activity (SBA) have not been systematically investigated, which is fundamental for understanding the human brain in health and disease. To quantify the psychometric performance of ME-rfMRI in precisely mapping inter-individual variations in SBA, we employed a psychometric design. We scanned 27 healthy adults with both ME-rfMRI and SE-rfMRI to assess short-term (minutes) test-retest reliability, as well as validity across eyes-open (EO) and eyes-closed (EC) resting states. Our results demonstrate that ME-rfMRI improves reliability relative to SE-rfMRI by 10.8% for amplitude of low-frequency fluctuation (ALFF), 4.4% for regional homogeneity (ReHo), and 8.0% for voxel-mirrored homotopic connectivity (VMHC) in cortical regions, and by 12.5% for ALFF, 8.3% for ReHo, and 4.0% for VMHC in subcortical regions. This enhancement is achieved by increasing inter-individual variability while reducing intra-individual variability. Notably, ME-rfMRI accentuates inter-individual variability in the unimodal cortex and clearly delineates two parallel systems with distinct variability patterns within the motor cortex. Concurrently, ME-rfMRI increases effect sizes (4%-8%) for detecting individual differences between EO and EC resting states. Interestingly, ME-rfMRI reveals differential effects of eye closure on two intertwined systems in the primary motor and sensory cortices, extending previous findings. Computational simulations indicate that, compared to SE-rfMRI, ME-rfMRI facilitates experimental designs with reduced costs (i.e., 4%-11% smaller sample sizes) for precise mapping of individual differences. These findings establish, for the first time, the psychometric performance of ME-rfMRI measurements, supporting its potential utility in personalized neuroscience applications, including neurodevelopment and brain disorders.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Yuan, L.-X., Chen, Z., Chao, J., Chen, X., Shao, B., Gong, Z.-Q., Hsu, Y., Zang, Y.-F., Zuo, X.-N., He, H.. 2026-01-16. Reliability and validity of multi-band multi-echo fMRI. https://doi.org/10.64898/2026.01.16.699838

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗